Market Tracker

02/23 6:21am ET

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

15.29
Delayed Data
As of Feb 22
 +0.08 / +0.53%
Today’s Change
8.37
Today|||52-Week Range
19.62
+10.56%
Year-to-Date
3 Stocks We're Watching in the First Quarter
Feb 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close15.21
Today’s open15.17
Day’s range15.01 - 15.37
Volume522,582
Average volume (3 months)667,424
Market cap$1.6B
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+96.24%
Earnings growth (this year)-3,040.00%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+468.89%
P/E ratioNM
Price/Sales10.61
Price/Book5.51

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+1.70+5.93%
HCMHutchison China Medi...+0.08+0.60%
TBPHTheravance Biopharma...-0.74-2.35%
PCRXPacira Pharmaceutica...-1.00-2.27%
Data as of 4:00pm ET, 02/22/2017

Financials

Last reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$130.0M
Annual profit (last year)-$4.7M
Net profit margin-3.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts